Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/165617
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCalbet Llopart, Neus-
dc.contributor.authorPascini Garrigòs, Mireia-
dc.contributor.authorTell Martí, Gemma-
dc.contributor.authorPotrony Mateu, Míriam-
dc.contributor.authorMartins da Silva, Vanessa-
dc.contributor.authorBarreiro, Alicia-
dc.contributor.authorPuig i Sardà, Susana-
dc.contributor.authorCaptier, Malvehy J Guillaume-
dc.contributor.authorJames, Isabelle-
dc.contributor.authorDegardin, Nathalie-
dc.contributor.authorCarrera Álvarez, Cristina-
dc.contributor.authorMalvehy, J. (Josep)-
dc.contributor.authorEtchevers, Heather C.-
dc.contributor.authorPuig Butillé, Joan Anton-
dc.date.accessioned2020-06-15T15:35:16Z-
dc.date.available2021-04-23T05:10:24Z-
dc.date.issued2020-04-23-
dc.identifier.issn1755-148X-
dc.identifier.urihttp://hdl.handle.net/2445/165617-
dc.description.abstractCongenital melanocytic nevi (CMN) are cutaneous malformations whose prevalence is inversely correlated with projected adult size. CMN are caused by somatic mutations, but epidemiological studies suggest that germline genetic factors may influence CMN development. In CMN patients from the U.K., genetic variants in MC1R, such as p.V92M and loss-of-function variants, have been previously associated with larger CMN. We analyzed the association of MC1R variants with CMN characteristics in two distinct cohorts of medium-to-giant CMN patients from Spain (N = 113) and from France, Norway, Canada, and the United States (N = 53), similar at the clinical and phenotypical level except for the number of nevi per patient. We found that the p.V92M or loss-of-function MC1R variants either alone or in combination did not correlate with CMN size, in contrast to the U.K. CMN patients. An additional case-control analysis with 259 unaffected Spanish individuals showed a higher frequency of MC1R compound heterozygous or homozygous variant genotypes in Spanish CMN patients compared to the control population (15.9% vs. 9.3%; p = .075). Altogether, this study suggests that MC1R variants are not associated with CMN size in these non-UK cohorts. Additional studies are required to define the potential role of MC1R as a risk factor in CMN development.© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.ca
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.publisherWileyca
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1111/pcmr.12883-
dc.relation.ispartofPigment Cell & Melanoma Research, 2020-NA-
dc.relation.urihttps://doi.org/10.1111/pcmr.12883-
dc.rights(c) John Wiley & Sons, 2020-
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)-
dc.subject.classificationFenotip-
dc.subject.classificationMalalties de la pell-
dc.subject.classificationPolimorfisme genètic-
dc.subject.otherPhenotype-
dc.subject.otherSkin diseases-
dc.subject.otherGenetic polymorphisms-
dc.titleMelanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevica
dc.typeinfo:eu-repo/semantics/articleca
dc.date.updated2020-06-15T10:52:05Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina6311618-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.